The stock's fall snapped a two-day winning streak.

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...